Literature DB >> 21547656

[The Obeldicks concept. An example for a successful outpatient lifestyle intervention for overweight or obese children and adolescents].

M Dobe1, A Geisler, D Hoffmann, M Kleber, P von Köding, N Lass, S Müther, B Pohl, K Rose, A Schaefer, M L Többens, R Vierhaus, K Winkel, T Reinehr.   

Abstract

The outpatient lifestyle interventions Obeldicks (for 8- to 16-year-old obese children; 1-year intervention), Obeldicks Light (for 8- to 16-year-old overweight children; 6-month intervention), and Obeldicks Mini (for 4- to 7-year-old obese children; 1-year intervention) are based on nutrition education, physical activity, behavior therapy, and individual psychological care. Only 17% dropped out of the intervention, and 79% of the more than 1,000 participants reduced their degree of overweight. The mean SDS-BMI reduction was 0.4 (~1.5-2 kg/m(2) BMI reduction) and was associated with a significant improvement of hypertension, dyslipidemia, and disturbed glucose metabolism in the participants compared to an untreated control group. This efficiency was also proven by a multicenter randomized controlled trial. Furthermore, the quality of life of the participants improved significantly. Even 4 years after the end of intervention, the achieved weight loss was sustained. Training manuals and training seminars for professionals assist in the implementation of these lifestyle interventions at further locations.

Entities:  

Mesh:

Year:  2011        PMID: 21547656     DOI: 10.1007/s00103-011-1261-x

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  1 in total

1.  What Change in Body Mass Index Is Required to Improve Cardiovascular Outcomes in Childhood and Adolescent Obesity through Lifestyle Interventions: A Meta-Regression.

Authors:  Ahmed Y M El-Medany; Laura Birch; Linda P Hunt; Rhys I B Matson; Amanda H W Chong; Rhona Beynon; Julian Hamilton-Shield; Rachel Perry
Journal:  Child Obes       Date:  2020-08-11       Impact factor: 2.992

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.